Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
17,685,185
-
Total 13F shares
-
8,529,313
-
Share change
-
+7,778,863
-
Total reported value
-
$334,743,519
-
Put/Call ratio
-
92%
-
Price per share
-
$39.24
-
Number of holders
-
81
-
Value change
-
+$310,281,997
-
Number of buys
-
65
-
Number of sells
-
8
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) as of Q1 2024
As of 31 Mar 2024,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,529,313 shares.
The largest 10 holders included
Cormorant Asset Management, LP, Point72 Asset Management, L.P., Ikarian Capital, LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Octagon Capital Advisors LP, CITADEL ADVISORS LLC, JANUS HENDERSON GROUP PLC, MILLENNIUM MANAGEMENT LLC, and Assenagon Asset Management S.A..
This page lists
81
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.